About  |  Employment  |  Media Center  |  Staff  |  Events  |  Contacts  |  Español  |  Français اللغة العربية 

      Search the Council's Web site:


Maguire, Robin A., Andrea Wallace, Jose A. Fernández-Romero, Jifan Li, Mitchell Thorn, Kristin M. Sudol, Kanani E. Titchen, Robert W. Buckheit Jr., Tracy L. Hartman, and David M. Phillips. "Zinc-carrageenan (PC-710): A novel microbicide." (poster)

Abstract

INTRODUCTION: Carraguard®, which employs carrageenan as the active ingredient, is currently being evaluated in a Phase 3 trial in South Africa. In order to improve the strength of this microbicide we have bound zinc (Zn) to carrageenan. Zn has been proven safe for human use and demonstrates strong antiviral activity including activity against HIV-1, foot-and-mouth virus, human rhinovirus, influenza A and B, Semliki Forest virus, Sindbis virus, and HSV.

METHODS: Because zinc salts would be systemically absorbed via the vagina, we have developed a simple rapid method to bind zinc to carrageenan. PC-710 toxicity was determined by the MTT assay and a dye exclusion assay for trichomonas, as well as the impact on growth or inhibition of growth for several species of lactobacilli. Formulation efficacy was evaluated using peripheral blood mononuclear cells (PBMCs) to assay a panel of clinical isolates of Clade C viruses. The herpes simplex virus type 2 (HSV-2) mouse assay studied the effect of PC-710 in preventing vaginal and rectal infection by HSV-2. Formulation stability was assayed by analysis of zinc content, pH, viscosity, and in vitro HIV activity.

RESULTS: PC-710 was found to be a stable, nontoxic microbicide that does not impact on the growth of lactobacilli. The EC50 of 10 different clinical isolates of Clade C HIV-1 was determined for Carraguard and PC-710. Carraguard blocked 9 of the 10 viruses at concentrations below 160μg/mL. PC-710 blocked all 10 viruses, on average, at concentrations an order of magnitude less than Carraguard. In the HSV-2 mouse system Carraguard protects almost all mice that are challenged with a 90%–100% infectious viral dose. However, PC-710 prevents infection at 1,000 times this challenge dose, and remains active in the mouse vagina for 24 hours. PC-710 is significantly more effective than Carraguard in preventing HSV-2 infection following rectal application as well as killing trichomonas. In addition, PC-710 can protect mice if administrated up to 4 hours post-viral challenge.

CONCLUSION: PC-710 is an exceptionally potent broad-spectrum microbicide. Our findings suggest that PC-710 could be effective if applied up to 24 hours prior to sexual activity, or even if applied 4 hours after sexual activity, as well as having potential as a rectal microbicide.

Poster Session
Monday, 24 April 2006, 12:30–1:30 pm
Tuesday, 25 April 2006, 12:30–1:30 pm

Microbicides 2006

 

 



Print this page

@
E-mail this page

This page updated
3 April 2006